Mergers & Acquisitions - Mergers & Acquisitions, Retrophin

Filter

Popular Filters

Retrophin to acquire Manchester Pharma in $62.5 million deal

Retrophin to acquire Manchester Pharma in $62.5 million deal

13-02-2014

USA-based Retrophin has signed an agreement to acquire Manchester Pharmaceuticals, a privately-held specialty…

Cardio-vascularChenodalManchester PharmaceuticalsMergers & AcquisitionsPharmaceuticalRare diseasesRetrophinVecamyl

Retrophin pulls out of deal to acquire Transcept Pharmaceuticals

17-12-2013

USA-based Retrophin says it has withdrawn its unsolicited offer to acquire all the shares of Transcept…

Mergers & AcquisitionsPharmaceuticalRetrophinTargacept

Retrophin to acquire Kyalin Biosciences; in-licenses Syntocinon

13-12-2013

In a second takeover bid within a matter of months, USA-based Retrophin announced that it will acquire…

Kyalin BiosciencesLicensingMergers & AcquisitionsNeurologicalNorth AmericaNovartisPharmaceuticalRetrophinSyntocinonWomen's Health

Retrophin ups unsolicited offer to buy Transcept Pharma shares not already owned

Retrophin ups unsolicited offer to buy Transcept Pharma shares not already owned

20-09-2013

USA-based Retrophin (OTCQB: RTRX) has made a proposal to the board of directors of Transcept Pharmaceuticals…

Mergers & AcquisitionsPharmaceuticalRetrophinTranscept Pharma

Back to top